Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Late relapse after CAR-T cell therapy for adult patients with hematologic malignancies: A definite evidence from systematic review and meta-analysis on individual data
Alessia Zinzi, Mario Gaio, Valerio Liguori, et al.
Pharmacological Research (2023) Vol. 190, pp. 106742-106742
Open Access | Times Cited: 13

Showing 13 citing articles:

A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023
Qing Huang, Huimin Li, Yuan Zhang
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 7
The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia
Martijn W. C. Verbeek, Vincent H. J. van der Velden
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4881-4881
Open Access | Times Cited: 5
CAR-T cell therapy: Efficacy in management of cancers, adverse effects, dose-limiting toxicities and long-term follow up
Mohamed Elmarasi, Islam Elkonaissi, Ahmed Elsabagh, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112312-112312
Open Access | Times Cited: 4
Implementation of chimeric antigen receptor (CAR) T-cell therapy in the NHS: prospects, promises and pitfalls
Ruff Joseph Macale Cajanding
British Journal of Nursing (2025) Vol. 34, Iss. 5, pp. S20-S30
Closed Access
Progress of immune senescence in multiple myeloma treatment resistance
Yanan Jia, Lixiang Yan, Chenyang Fan, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Minimal residual disease assessment following CD19‐targeted therapy in B‐cell precursor acute lymphoblastic leukemia using standardized 12‐color flow cytometry: A EuroFlow study
Martijn W. C. Verbeek, Michaela Reiterová, Anna Laqua, et al.
HemaSphere (2025) Vol. 9, Iss. 4
Open Access
CAR T-cell therapy in renal cell carcinoma: opportunities, challenges, and new strategies to overcome
Mahan Mohammadi, Houshang Najafi, Pantea Mohammadi
Medical Oncology (2025) Vol. 42, Iss. 6
Closed Access
Frequently Asked Questions on Imaging in Chimeric Antigen Receptor T-Cell Therapy Clinical Trials
Sang Eun Won, Eun Sung Lee, Chong Hyun Suh, et al.
Korean Journal of Radiology (2025) Vol. 26, Iss. 5, pp. 471-471
Closed Access
Efficacy of Chronic Use of Sodium–Glucose Co-transporter 2 Inhibitors on the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Type 2 Diabetes Mellitus Following Coronary Procedures: A Systematic Review and Meta-Analysis
Kyriakos Dimitriadis, Angeliki Vakka, Nikolaos Pyrpyris, et al.
American Journal of Cardiovascular Drugs (2024)
Closed Access | Times Cited: 3
The current socioeconomic and regulatory landscape of immune effector cell therapies
Chiranjeevi Sainatham, Devvrat Yadav, Aravind Dilli Babu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Broadening the horizon: potential applications of CAR-T cells beyond current indications
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Recent advances in genomics and therapeutics in mantle cell lymphoma
Tingxun Lu, Jie Zhang, Jenna McCracken, et al.
Cancer Treatment Reviews (2023) Vol. 122, pp. 102651-102651
Closed Access | Times Cited: 4
Axicabtagene Ciloleucel (Yescarta)
CADTH
Canadian Journal of Health Technologies (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Sustained efficacy of chimeric antigen receptor T-cell therapy in central nervous system lymphoma: a systematic review and meta-analysis of individual data
Jing Zhou, Zhenhao Wang, Hanyu Wang, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 1
Mini review: Advances and challenges in CAR-T cell therapy: from early chimeric antigen receptors to future frontiers in oncology
Candela Ceballos, María C. Viguria, Carlos Panizo, et al.
Frontiers in Hematology (2023) Vol. 2
Open Access
Page 1

Scroll to top